Abs and B cell responses (9). A recent study suggests that B cell precursor frequency and BCR 47 avidity contribute to the subdominance of conserved HIV GP160 epitopes (10). Other studies 48 suggest, however, that GC are more permissive than previously thought, allowing B cells with 49
LNs and 61% of the iliac LNs tested, while after i.m. immunization PE was detectable only in 22% 131 of the LNs analyzed (for both the inguinal and iliac) (p=0.0022; Fisher's exact test). If we average 132 the amount of PE detected (with our limit of detection being 0.1 ng/ml) in the popliteal LN after 133 f.p. immunization was at least 14-and 30-fold higher, respectively, than in draining inguinal and 134 iliac LN after i.m. immunization. immunization also increased switched, and IgM + stem-specific stem B cells ( Fig. 3D- 
E). 152
We were unable to detect IgG or IgM anti-stem Abs in i.m. immunized mice (Fig. 3F) . f.p. 153 immunization generated stem specific IgG and IgM serum responses in the ~50% of mice with 154 the highest levels of GC B cells (on average 20x more abundant than seronegative mice (Fig. 3C)) . Finally, we determined the influence of f.p. vs i.m. HA immunization on the ratio of T follicular 167 regulatory cells (Tfr) to T follicular helper (Tfh) cells, which has been reported to regulate Ab 168 responses (25). Although f.p. immunization generated higher frequencies of both Tfh and Tfr 169 compared to i.m. (Fig. S10A-B-C) , the Tfr/Tfh ratio was doubled after i.m. immunization, 170
suggesting an additional contribution to the suppression of stem-specific response (Fig. 3G) experiments with 4 mice each (n=12 for groups 1, 2, 4 and n=10 for group 3). Bar is mean ± SEM, 302 statistical analysis was performed using one-way ANOVA with Tukey multiple comparison test. 303 using TMB substrate (KPL biomedical) and halted with 0.1N HCl. Plates were read at 450nm. For 93 endpoint titer determination, sera from at least six mice immunized with irrelevant proteins were 94 tested using the same conditions. Cutoff for positivity was determined using the formula from 95 (7). For quantification of head Ab titer, the serum was pre-absorbed using recombinant stem as 96 follows. 5ug of his-tagged stem was incubated with Talon-Agarose resin in PBS, following 1h 97 incubation at 4°C the slurry was washed with PBS and then incubated with sera o.n. in rotation 98 at 4°C. The resin was spun at 300xg and allowed to settle and the supernatant collected and used 99 for ELISA. For each sera a pre-and a post-absorption samples were run on all the recombinant 100 proteins to verify depletion. For endpoint titer determination "Head titer" was considered based 101 on reactivity of depleted sera on H1 while "stem titer" on the reactivity of serum pre-depletion 102 on stem. 103
For competition with stem mAbs FI6 and 310-16G8 ELISA was performed as above with the 104 following modifications: H1 HA coated plates were incubated with pooled HA (group 1) or stem 105 (group 2) sera, after washed the human stem mAbs were dispensed to the wells at the 106 concentration giving 75% of their maximum signal. Plates were detected with anti-human-kappaderived from D4 viruses as described in (8). After blocking, plates were incubated with two-fold 110 serially diluted sera starting from 1:100 for 1h at RT. Following washes with PBST, serum binding 111 was detected using anti-mouse-kappa secondary Ab at 1:2000 for 1h at RT. ELISA binding is 112 expressed as area under the curve, calculated using GraphPad Prism as described before (8). stem Abs titer (as in Fig. 2A)(A) or stem-specific IgG2 (As in Fig. 2B) 
